This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at stem-cell@magnusconference.com or call + 1 (702) 988 2320.
The term "stem cells" refers to a variety of cells that have self-renewal and differentiation capabilities, many of which could be used therapeutically. As more stem cell-based medicines reach clinical trials, the necessity for strong methodologies and consistent procedures capable of reliably delivering the required volumes of cells while verifying the product's safety and usefulness becomes obvious. Over the last 50–60 years, the stem cell field has advanced dramatically. The development of cell-engineering techniques has ushered in a new era of stem cell-based therapeutics, considerably extending their therapeutic potential. These next-generation stem cells are being employed as 'Trojan horses' to increase medicine and oncolytic virus delivery to stubborn tumours, and they're also being modified with angiogenic, neurotrophic, and anti-inflammatory chemicals to speed tissue healing.
Title : The adult stem cells and the cancer stem cells in the context of ovarian cancer
Pushpam Kumar Sinha, Independent Researcher, India
Title : Cell based therapies in articular cartilage repair
Anjali Goyal, NHL Municipal Medical College, India
Title : Comparative study on the effect of adipose-derived stem cells versus alpha-lipoic acid inautologus fat graft survival
Sahar Mohamed Mahdy Omar, Ain Shams University, Egypt
Title : Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Asma Alanazi, King Saud Bin Abdulaziz University, Saudi Arabia
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of Mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Optimized protocol for generating clinical grade umbilical cord tissue mesenchymal stem cell for cell therapy in various disease
Rekha Kumari, Institute of Liver and Billiary Sciences, India